Clinical Trials
23 trialsNCT03645928 2026-05-15
Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors
Iovance Biotherapeutics, Inc.
Phase 2 Terminated
NCT07310784 2026-05-12
A Phase II Trial of LM103 in Advanced Melanoma
Suzhou BlueHorse Therapeutics Co., Ltd.
Phase 2 Recruiting
NCT07492680 2026-03-25
A Study of BMS-986504 Monotherapy and in Combination With Other Agents in Participants With Advanced and/or Metastatic Solid Tumors With Homozygous MTAP Deletion (MountainTAP-5)
Bristol-Myers Squibb
Phase 2 Not yet recruiting
NCT01827111 2022-02-08
Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic Melanoma
M.D. Anderson Cancer Center
Phase 2 Completed
NCT01676649 2021-02-18
Ipilimumab With Carboplatin and Paclitaxel in Patients With Unresectable Stage III and Stage IV Melanoma
Jewish General Hospital
Phase 2 Active not recruiting
NCT02617849 2021-02-18
Pembrolizumab With Carboplatin/Paclitaxel in Patients With Metastatic Melanoma
Jewish General Hospital
Phase 2 Unknown
NCT01704287 2020-05-18
KEYNOTE 002
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT01107665 2019-08-07
Pazopanib and Paclitaxel as First-Line Treatment for Subjects With Unresectable Stage III and Stage IV Melanoma
University of California, Irvine
Phase 2 Completed
NCT01666418 2018-10-16
Pilot Study Investigating the Metabolic Activity and Transcriptional Profiling in Vivo in Tumor Biopsies in Melanoma Patients During Treatment With Pazopanib Alone and in Combination With Paclitaxel
University of Zurich
Phase 2 Completed
NCT01174238 2018-06-08
A Two Arm Trial of Axitinib and Carboplatin/Paclitaxel in Melanoma
University of California, San Francisco
Phase 2 Completed
NCT02054884 2018-05-18
F16IL2 Plus Paclitaxel in Metastatic Merkel Cell Carcinoma
Philogen S.p.A.
Phase 2 Terminated
NCT01009515 2017-10-18
Carboplatin, Paclitaxel, and Temozolomide for Patients With Metastatic Melanoma
New Mexico Cancer Research Alliance
Phase 2 Terminated
NCT00434252 2017-07-18
BEAM
Genentech, Inc.
Phase 2 Completed
NCT02023710 2017-05-09
Bevacizumab Combined With Carboplatin Plus Paclitaxel Chemotherapy to Treat Metastatic Mucosal Melanoma
Peking University Cancer Hospital & Institute
Phase 2 Unknown
NCT00976573 2017-04-04
Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
Alliance for Clinical Trials in Oncology
Phase 2 Completed
NCT01200342 2016-02-11
Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00568451 2015-12-30
Paclitaxel and Carboplatin or Temozolomide in Treating Patients With Stage IV Melanoma
Mayo Clinic
Phase 2 Terminated
NCT00984464 2015-04-10
Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma
Oncolytics Biotech
Phase 2 Completed
NCT00329641 2014-07-31
Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye
National Cancer Institute (NCI)
Phase 2 Completed
NCT01014351 2014-03-26
Study of Everolimus With Paclitaxel and Carboplatin in Patients With Metastatic Melanoma
SCRI Development Innovations, LLC
Phase 2 Completed
NCT00278122 2013-12-10
Paclitaxel and GM-CSF in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
University of Virginia
Phase 2 Suspended
NCT00255762 2013-10-28
Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Stage IV Melanoma That Cannot Be Removed By Surgery
National Cancer Institute (NCI)
Phase 2 Completed
NCT00288041 2013-03-05
Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Metastatic Melanoma
National Cancer Institute (NCI)
Phase 2 Completed